BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Alkermes

About Alkermes:

Alkermes® is a world leader in the development of products based on sophisticated drug delivery technologies-and an emerging pharmaceutical company.

Alkermes develops sustained-release injectable drugs using their ProLease® and Medisorb® technologies, and inhaled formulations based on their proprietary AIR® pulmonary technology.

In partnership with Johnson & Johnson, Alkermes is marketing Risperdal® Consta™, a long-acting newer-generation antipsychotic for the treatment of schizophrenia. Developed with Medisorb® technology,

 

Pipeline:

Phase IIIVivitrexAlchol Dependence
Phase IIMedisorbDiabetes
Phase IIAIR InsulinDiabetes
Phase IAIR hGHGHD
Phase IAIR EpinephrineAnaphylaxis

Alkermes' lead product candidate, Vivitrex (naltrexone), is a once-a-month injection for the treatment of alcohol dependence.

 

 

Pipeline Chart



More on Alkermes
:

Home Page

Key Statistics fo Alkermes

Basic Chart for Alkermes

Analyst Opinion

Analysts Estimates

 
Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright © 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com